Fresenius Medical Care AG & Co. KGaA (FME)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 40.46 |
|---|---|
| 52-week range | 34.57 – 47.54 |
| Return, 1 month / 3 months | +2.2% / −5.9% |
| Return, 1 year / 3 years | −9.5% / +36.3% |
| Trend | Uptrend |
| RSI (14) | 58 |
| Volatility (1 year) | 30.2% |
| Worst drawdown (1 year) | -25.8% |
| Average daily value traded | 34.19M EUR |
| Dividend yield | 3.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Fresenius Medical Care is a healthcare company focused on kidney care. It provides dialysis treatment to patients with chronic kidney failure through a network of dialysis clinics, and it develops and makes dialysis machines, filters and related medical products. Its customers include patients, hospitals and healthcare providers in many countries. The company is based in Germany and serves markets around the world.
On this site Fresenius Medical Care AG & Co. KGaA appears as a stock on the XETRA Stock Exchange (Germany), code FME, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Fresenius Medical Care AG & Co. KGaA (FME) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 40.46 on 23 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 189 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 9.5% and over the last three months it fell 5.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 62 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 4.1% | ||
| From 52-week high | -14.1% | ||
| Momentum | 48 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -5.9% | ||
| 6-month return | 7.9% | ||
| 12-month return, skipping the last month | -11.4% | ||
| Stability (higher is calmer) | 64 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 30.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -25.8% | ||
| Liquidity | 96 · Strong | Trades actively. | |
| Average daily value traded | 34.19M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 60 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.7% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +2.3% |
|---|---|
| 1 month | +2.2% |
| 3 months | −5.9% |
| 6 months | +7.9% |
| 1 year | −9.5% |
| 3 years | +36.3% |
| 5 years | −23.6% |
Signals
| 50-day / 200-day average | 39.37 / 38.88 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.17 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 May 2026 | EUR 1.4900 |
| 23 May 2025 | EUR 1.4400 |
| 17 May 2024 | EUR 1.1900 |
| 17 May 2023 | EUR 1.1200 |
| 13 May 2022 | EUR 1.3500 |
| 21 May 2021 | EUR 1.3400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.